LFM-A13 is a potent BTK, JAK2, PLK inhibitor, inhibits recombinant BTK, Plx1 and PLK3 with IC50s of 2.5 µM, 10 µM and 61 µM. LFM-A13 has antiproliferative activity and anticancer activity. LFM-A13 can be used in cancer-related research[1][3][4]
Molecular Weight:
360.00
Purity:
99.65
CAS Number:
[62004-35-7]
Formula:
C11H8Br2N2O2
Target:
Btk,JAK,Polo-like Kinase (PLK)
Application Notes:
MCE Product type: Biochemical Assay Reagents
* VAT and and shipping costs not included. Errors and price changes excepted